Downloadable Slides

Share

Program Content

Activities

  • BTKi for MCL
    BTK Inhibitors for Mantle Cell Lymphoma: Overview and Current Treatment Landscape
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 05, 2024

    Expires: December 04, 2025

  • Frontline BTKi in MCL
    Optimizing Frontline Treatment for MCL: Considerations for BTK Inhibitors in Younger, Fit Patients
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 05, 2024

    Expires: December 04, 2025

  • BTKi in MCL Older Patients
    Optimizing Frontline Treatment for MCL: Considerations for BTK Inhibitors in Older Patients
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 05, 2024

    Expires: December 04, 2025

Faculty

cover img faculity

Brad Kahl, MD

Professor of Medicine
Washington University School of Medicine
Director, Lymphoma Program
Siteman Cancer Center
St. Louis, Missouri

cover img faculity

John P. Leonard, MD

Senior Associate Dean for Innovation and Initiatives
Richard T. Silver Distinguished Professor of Hematology and Medical Oncology
Weill Cornell Medicine
NewYork-Presbyterian
New York, New York

cover img faculity

Julie M. Vose, MD, MBA

Payne Presidential Chair
Chief, Division of Hematology/Oncology
University of Nebraska Medical Center
Buffett Cancer Center
Omaha, Nebraska

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an educational grant from AstraZeneca.

AstraZeneca